Virtual Cell Models, Tahoe-100 and Data for AI-in-Bio with Vevo Therapeutics and the Arc Institute
On this week’s episode of No Priors, Sarah Guo is joined by leading members of the teams at Vevo Therapeutics and the Arc Institute – Nima Alidoust, CEO/Co-Founder at Vevo Therapeutics; Johnny Yu, CSO/Co-Founder at Vevo Therapeutics; Patrick Hsu, CEO/Co-Founder at Arc Institute; Dave Burke, CTO at Arc Institute; and…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from No Priors: Artificial Intelligence | Technology | Startups
See all episodes →
43%From Restoring Sight to Reimagining the Brain, with Max Hodak
35%Redefining Chip Architecture with Arm CEO Rene Haas
33%Rethinking Legacy Data Infrastructure with Eon Co-Founders Ofir Ehrlich and Gonen Stein
Similar episodes from other shows
More like No Priors: Artificial Intelligence | Technology | Startups →
🔬Causal Models Need Causal Data - Xaira’s X-Cell model for Drug Discovery (Bo Wang & Ci Chu, Chief Discovery Officer & Chief AI Scientist)
Faster Science, Better Drugs
EP 29: AlphaFold, AlphaGenome, And the Scientific Revolution
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.